ADAR1 CAPITAL MANAGEMENT, LLC purchased 4.8% of their position (42.92K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $57.1K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/5/2026ACC: 0001940272-26-000022
10% Owner
Since May 2026
+42.92K
Net shares
Net buyer
$57.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
42.92K acquired
Non-Derivative Transactions3
Common Shares
Indirect
Shares
+16.43K
Price / share
$1.33
Trade value
$21.85K
% of position
1.8%
10/1/2026
892.10K→908.53K
Common Shares
Indirect
Shares
+8.31K
Price / share
$1.33
Trade value
$11.05K
% of position
0.9%
10/2/2026
908.53K→916.84K
Common Shares
Indirect
Shares
+18.18K
Price / share
$1.33
Trade value
$24.18K
% of position
2.0%
10/5/2026
916.84K→935.02K
Total
Net shares
+42.92K
Net value
$57.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 10/1/2026 | P · Purchase | +16.43K | $1.33 | $21.85K | 1.8% | 892.10K | 908.53K |
| Common Shares Indirect | 10/2/2026 | P · Purchase | +8.31K | $1.33 | $11.05K | 0.9% | 908.53K | 916.84K |
| Common Shares Indirect | 10/5/2026 | P · Purchase | +18.18K | $1.33 | $24.18K | 2.0% | 916.84K | 935.02K |
| Total | +42.92K | $57.08K | ||||||
Derivative Transactions0
No derivative transactions reported